“…The type II enzyme with the high affinity markedly inhibited lymphomas in mice, whereas the type I enzyme with the low affinity was ineffective (Schwarts et al, 1966). Their properties have been studied in Escherichia coli (Bagert and Röhm, 1989;Harms et al, 1991aHarms et al, , 1991b, Erwinia carotovora (Kotzia and Labrou, 2005), Erwinia chrythanthemi (Aghaiypour et al, 2001), Pseudomonas aeruginosa (Geckil et al, 2006), Saccharomyces cerevisiae (Kim et al, 1988), and Pyrococcus horikoshii (Yao et al, 2005). Especially, the type II enzymes of Escherichia coli and Erwinia chrysanthemi have been intensively investigated with respect to their antitumor activity.…”